Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial

Eur J Heart Fail. 2007 Feb;9(2):110-2. doi: 10.1016/j.ejheart.2007.01.004. Epub 2007 Jan 30.

Authors

Dirk J van Veldhuisen, John J V McMurray; RED-HF Executive Committee

PMID: 17270493
DOI: 10.1016/j.ejheart.2007.01.004

No abstract available

Publication types

Editorial

MeSH terms

Erythropoietin / biosynthesis*
Erythropoietin / therapeutic use
Heart Failure / drug therapy*
Humans
Randomized Controlled Trials as Topic / methods*
Treatment Outcome*

Substances

Erythropoietin